HHS Secretary Xavier Becerra speaks during a news conference on June 28. Becerra said HHS is continuing to monitor the response to monkeypox across the country.

HHS Secretary Xavier Becerra speaks during a news conference on June 28. Becerra said HHS is continuing to monitor the response to monkeypox across the country. Alex Wong/Getty Images

There’s No Decision Yet on Whether to Declare a Public Health Emergency for Monkeypox

In the meantime, the Biden administration is working to make more vaccines available as the case numbers rise.

The Biden administration has not made a decision on declaring monkeypox a public health emergency, amid mounting pressure for such a designation, including from the president’s own political party. 

The World Health Organization declared the monkeypox outbreak a global health emergency over the weekend. As of July 27, there have been over 20,000 cases detected globally in 77 countries and in the United States there have been over 4,600 reported cases across 48 jurisdictions. Federal public health officials have been saying recently that they expect the case count to continue to increase before it declines. 

“We continue to monitor the response throughout the country on monkeypox,” said Xavier Becerra, secretary of Health and Human Services, on a briefing call Thursday, during which he touted the administration’s progress on vaccines, tests and therapeutics. “And we weigh any decision on declaring a public health emergency based on the response we’re seeing throughout the country. Bottom line is we need to stay ahead of this and be able to end this outbreak.” 

In an interview with CNN earlier this week Becerra said, “We declare public health emergencies based on the data and the science, not on our worries.” As was the case with COVID-19, “our scientists are making decisions as we speak.” 

Politico reported on Wednesday evening that HHS is expected to declare monkeypox a public health emergency within the coming days. 

Twenty-two House Democrats backed a resolution this week advocating for HHS to declare the monkeypox outbreak a public health emergency. Last week, 50 House Democrats sent a letter to the president, endorsed by the advocacy organizations PrEP4All, Human Rights Campaign, Equality California, Silver State Equality, GLMA: Health Professionals Advancing LGBTQ Equality, and Whitman-Walker Health, saying the administration should declare the public health emergency as it would “make available a number of authorities to accelerate the federal response and tap into additional resources to procure vaccines and distribute them swiftly across the country.” 

Dr. Eric Feigl-Ding, an epidemiologist and health economist who is the co-founder of the World Health Network, tweeted on Thursday “the monkeypox situation is spiraling out of control.” The White House “needs to hurry up its public health emergency declaration.”

Vaccination Update

As for vaccinations, as of July 27, HHS has distributed more than 338,000 doses of the JYNNEOS vaccines and they are making an additional 786,000 doses available starting on Friday, said Dawn O’Connell, who leads HHS’s newly reclassified Administration for Strategic Preparedness and Response. Those new doses were produced at a facility in Denmark and the Biden administration’s process to inspect and approve them saw much scrutiny. 

O’Connell said the government’s allocation formula will be made publicly available soon. Also, “when including doses already distributed, the federal government will have secured more than 6.9 million monkeypox vaccine doses by mid-2023.”  

The Centers for Disease Control and Prevention has been working closely with HHS and the Administration for Strategic Preparedness and Response on updating the federal vaccine allocation strategy. 

With the newly announced additional doses “we have again updated the plan for allocated doses to take into account two key factors. The total population of people at risk in the jurisdiction and the number of new cases in each jurisdiction since the last allocation,” said Capt. Jennifer McQuiston, deputy director for the CDC’s division of high consequence pathogens and pathology. 

“This update gives greater weight to prioritize the vaccine in areas with the greatest number of people at risk, which is men who have sex with men who have HIV or who are eligible for HIV prep, while still considering where we are seeing cases increase,” she said. CDC will also ensure “that jurisdictions have the doses they need to complete the second dose of the two dose vaccine regime for those who have already been vaccinated over the last month,” she said.  

Additionally, the CDC is poised to make monkeypox a “nationally notifiable condition,”  which would fill in some, but not all of the gaps in their data collection on monkeypox, Politico first reported. 

“The new monkeypox surveillance case definition, which goes into effect on August 1, 2022, updates the criteria for clinical and laboratory reporting to public health and for jurisdiction data sharing with CDC during the response,” CDC spokesperson Kristen Nordlund told Government Executive on Thursday. “It also establishes the criteria that will be used for continued routine public health monitoring and action after the current response is over.” 

A New Funding Proposal 

Senate Appropriations Committee Chairman Patrick Leahy, D-Vt.; Senate Health, Education, Labor and Pensions Committee Chairwoman Patty Murray, D-Wash.; and Sen. Chris Coons, D-Del., chairman of the Appropriations Subcommittee on State, Foreign Operations and Related Programs, on Thursday released a new $21 billion emergency supplemental funding bill for the next phase of the COVID-19 pandemic and “other emerging diseases that pose a significant threat to public health,” which could include monkeypox. 

When asked on the briefing call if HHS expects this funding to go to monkeypox, Becerra said: “We have communicated to Congress what we believe would be a good path forward on monkeypox, what it would take in terms of resources and authorities.” Also, officials “have shared with Congress as well what it takes to continue the fight on covid and hope that Congress will act on both.” The secretary vowed his department will continue to provide any assistance or information sought by lawmakers. 

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.